The NoLymiT team is principal investigator of the European THERAVLINFO project.
THERAVLINFO is an advance in the biomedical translation of preclinical lymphoma knowledge and models generated in IMLINFO (EFA 281/16), in order to improve the survival and quality of life of patients with hematological cancer.
OBJECTIVE: To determine the effectiveness of new immunotherapy treatments through the creation of a NHL tumour bank associated with a 3D culture platform. The project is part of axis 1 of the POCTEFA programme: Boosting innovation and competitiveness.
More informations
Centre de Recherches contre le Cancer de Toulouse (Oncopole)
Toulouse - FR
CRCT-Oncopole Follow 1,433 1,279
Compte officiel du Centre de Recherches en Cancérologie de Toulouse
;
🇬🇧Cytidine deaminase-dependent mitochondrial biogenesis as a potential vulnerability in pancreatic cancer cells. ImPact team @CordelierPierre article from @crctoncopole published in @CommsBio
➡️https://www.crct-inserm.fr/en/targeting-the-energy-production-process-in-pancreatic-cancer-cells-which-relies-on-an-enzyme-called-cytidine-deaminase-could-make-these-cells-more-vulnerable/
Nous contacter
+33 5 82 74 15 75
Nous rejoindre ?
